Ignite Creation Date:
2024-05-06 @ 4:10 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04898010
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2021-05-18
Brief Title:
The Selective Cytopheretic Device SCD for Acute Kidney Injury AKI and Hepatorenal Syndrome HRS Type I
Sponsor:
Lenar Yessayan
Organization:
University of Michigan
Study Overview
Official Title:
Investigator Initiated Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device SCD to Treat ICU Patients With Acute Kidney Injury AKI and Hepatorenal Syndrome HRS Type I
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research study is being done to learn what effect 7 days of treatment with the Selective Cytopheretic Device SCD will have on these white blood cells in the bloodstream of patients with hepatorenal syndrome and to learn whether it has any effect on the blood circulation and kidney function
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
True
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None